The FDA’s September 21, 2026 K261725 letter finds OtoCompanion substantially equivalent for its enclosed indications.
The indications specify medical-professional use for patients aged six months–21 years, with middle-ear fluid as the detection target.
Ironsides Medical’s submitted summary describes local macOS processing of specified otoscopic images. It calls the software adjunctive and keeps clinical decisions with the clinician.
The summary says a low-confidence output withholds classification and requests image recapture. This account describes the documented workflow without assessing clinical performance.
Sources: FDA letter and indications; Ironsides Medical’s September 2026 510(k) Summary. Original ENT Daily Dispatch paraphrase; no endorsement implied.
User, image-input and fallback boundaries belong alongside the decision date when describing automated otoscopy.
Go to the source.
FDA record ↗Letter, indications and submitted summary ↗This methods explainer describes public reference records. It does not establish study results, a product’s current authorization or treatment suitability.
